TAS:: 75 0893:: TAS novel makscientific, LLC, azetidine CB1 antagonists

Ended Definitive Contract Awarded Feb 4, 2011 Last action Oct 6, 2014

Contract number: HHSN271200900031C
Awardee: Makscientific LLC UEI J2NHTDAJGK24
Awarding agency: National Institute on Drug Abuse National Institutes of Health, Department of Health and Human Services
Obligated: -$400

Award facts

Contract value 0% obligated: $749,600.00 Current and potential, with all options
Completion date 100% complete: Sep 29, 2013 Current and potential, with all options
NAICS code: 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
PSC: AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside: No set-aside
Competition: Not Available for Competition · 1 offer Only One Source
Pricing: Fixed Price Award Fee
Place of performance: Mystic, Stonington, CT, USA

Award details come from SAM.gov/FPDS.

Action	Obligated	Date
Close Out 9	-$400	Oct 6, 2014
Other Administrative Action 8	$0	Dec 12, 2013
Other Administrative Action 7 · Other functions: novel azetidine CB1 antagonists. September 30, 2009 - september 29, 2013. N44DA-9-8874.	$0	Mar 29, 2013
Other Administrative Action 6	$0	Nov 19, 2012
Other Administrative Action 5 · Other functions: novel azetidine CB1 antagonists. September 30, 2009 - march 29, 2013. N44DA-9-8874.	$0	Sep 25, 2012
Other Administrative Action 4 · Novel azetadine CB1 antagonists	$0	Sep 22, 2011
Other Administrative Action 3	$0	Feb 4, 2011

HHSN271200900031C was awarded to Makscientific LLC by National Institute on Drug Abuse (National Institutes of Health) on February 4, 2011.

The government has obligated -$400 on HHSN271200900031C. Its current value, with exercised options, is $749,600.

The extent of competition for HHSN271200900031C was not available for competition. The government received 1 offer.

On GovTribe

Try for free Login